Volume 19, Issue 11 e202200345
Research Article

Ellagic Acid Alleviates Mice Intestinal Ischemia-Reperfusion Injury: A Study Based on Transcriptomics Combined with Functional Experiments

Shuyuan Fan

Shuyuan Fan

College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029 China

Search for more papers by this author
Yue Xu

Yue Xu

College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029 China

Search for more papers by this author
Kun Li

Corresponding Author

Kun Li

College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029 China

Search for more papers by this author
Bin Li

Corresponding Author

Bin Li

College of Pharmacy, Dalian Medical University, Dalian, 116044 China

Search for more papers by this author
Yunpeng Diao

Corresponding Author

Yunpeng Diao

College of Pharmacy, Dalian Medical University, Dalian, 116044 China

Dalian Anti-Infective Traditional Chinese Medicine Development Engineering Technology Research Center, Dalian, 116044 China

Search for more papers by this author
First published: 10 October 2022
Citations: 2

Abstract

Background: It has been reported that intestinal ischemia-reperfusion injury (IIRI) is closely related to inflammatory response, apoptosis and oxidative stress. Ellagic acid (EA) has been proved to have antioxidant and anti-inflammatory effects and can inhibit tumor angiogenesis. The purpose of this study was to investigate the protective effects of EA on IIRI in mice. Methods: A mouse model of IIRI was established by clamping the mesenteric artery. Effects and mechanisms of EA on IIRI were investigate by transcriptomics combined with functional experiments. Results: The symptoms of IIRI were reflected in significant increases in inflammatory factors such as TNF-α and IL-1β; significant increases in oxidative stress indicators such as MDA and GSH and decreases in SOD and promotion of the apoptotic protein Bax/Bcl-2. These indicators were significantly alleviated by EA. And after EA treatment, transcriptomics results identified AKT1 differentially expressed mRNAs mainly enriched in PI3K/AKT signalling pathway. Conclusion: This study illustrates the protective effects against IIRI, the possible mechanisms were also studied. This study provides new scientific information for the application of EA in IIRI therapy.

Graphical Abstract

Conflict of interest

The authors declare no conflict of interest.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.